U.S. Federal Register Tool

Naturalization Application Fee Adjustments

250th Anniversary of the Adoption of the Declaration of Independence

Schedules of Controlled Substances: Placement of Tianeptine in Schedule I

The Drug Enforcement Administration proposes placing the substance tianeptine (7-[(3-chloro-6,11-dihydro-6-methyl-5,5- dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, salts, and salts of isomers, esters, and ethers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle tianeptine.

Certain Mobile Electronic Devices; Notice of Request for Submissions on the Public Interest

Notice is hereby given that on July 1, 2026, the presiding administrative law judge ("ALJ") issued an Initial Determination on Violation of Section 337. The ALJ also issued a Recommended Determination on remedy and bonding should a violation be found in the above-captioned investigation. The Commission is soliciting submissions on public interest issues raised by the recommended relief should the Commission find a violation. This notice is soliciting comments from the public and interested government agencies only.

Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Biologics License Application (BLA) 125827, From Replimune, Inc. for Vusolimogene Oderparepvec

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Cellular, Tissue, and Gene Therapies Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.

Fisheries of the Northeastern United States; Omnibus Management Flexibility Amendment to New England Fishery Management Council Fishery Management Plans

NMFS proposes to implement the Omnibus Management Flexibility Amendment to the New England Fishery Management Council (Council) Fishery Management Plans (FMPs) (Amendment), as prepared by the Council. This proposed rule would allow for changes to the specifications process, in-season adjustment authority, and preparation of Council reports and reviews. The purpose of this action is to address the need for increased management flexibility and consistency across all the Council's FMPs.

Fisheries of the Caribbean, Gulf of America, and South Atlantic; Puerto Rico Fishery Management Plan; Amendment 4

NMFS proposes regulations to implement Amendment 4 to the Puerto Rico Fishery Management Plan (Puerto Rico FMP), as prepared and submitted by the Caribbean Fishery Management Council (Council). The proposed rule would reclassify rainbow runner from a reef fish to a pelagic fish under the Puerto Rico FMP. The proposed rule would implement management measures for rainbow runner based on the pelagic fish classification, including sector annual catch targets (ACTs) and accountability measures (AMs). The sector-specific annual catch limits (ACLs) would be retained after the reclassification. The purpose of this proposed rule and Amendment 4 is to ensure that rainbow runner is managed consistent with its life history characteristics, fishing patterns, and with the Council's management of other pelagic species.

Proposed Collection; 60-Day Comment Request: Generic Clearance for the Collection of Customer Participation and Performance Management With NIH Programs, Products, and Services (Office of the Director)

In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide an opportunity for public comment on proposed data collection projects, the National Institutes of Health, National Cancer Institute (NCI) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.

Pipeline Safety: Repair Criteria for Hazardous Liquid and Gas Transmission Pipelines

PHMSA proposes to modernize and to clarify the anomaly response criteria in the Federal pipeline safety regulations for gas transmission and hazardous liquid pipelines. Driven by twenty years of technological development, modern engineering concepts allow operators to identify, schedule, and remediate pipeline anomalies more effectively and in a less costly manner. PHMSA proposes incorporating these improved safety practices into its regulations by finalizing certain safety improvements advanced in recent rulemakings for gas transmission pipelines and extending those changes to hazardous liquid pipelines. In addition, PHMSA proposes certain non-substantive revisions to its gas and hazardous liquid repair regulations to improve compliance.

Submission for Review: 3206-NEW, Request for Reduction or Cancellation of Federal Employees Group Life Insurance (FEGLI), RI 76-30

The Office of Personnel Management (OPM), Retirement Services offers the general public and other federal agencies the opportunity to comment on OPM's submission to OMB for approval of a new information collection, Request for Reduction or Cancellation of Federal Employees Group Life Insurance (FEGLI), RI 76-30.